Rezolute prices $100 million underwritten offering of common stock and pre‑funded warrants

Rezolute announced the pricing of an underwritten public offering of 22,040,976 common shares at $3.87 each, together with pre‑funded warrants to purchase up to 3,800,000 shares at $3.869 per warrant. The company expects gross proceeds of about $100 million, with the transaction slated to close on or about November 16, 2026. Net proceeds will be used to fund commercialization of its ersodetug program, working capital and other corporate purposes.

The capital raise provides cash for product development and operations, but will dilute existing shareholders. The offering’s timing and size may affect short‑term liquidity and trading volume for the stock.

  • 1The offering price was $3.87 per common share.
  • 2Pre‑funded warrants were priced at $3.869 each.
  • 322,040,976 common shares were offered.
  • 4Up to 3,800,000 pre‑funded warrants were offered.
  • 5Gross proceeds are expected to total approximately $100 million.
  • 6The offering is expected to close on or about November 16, 2026.

Sources